“Your Diagnostics Platform Partner”

Plexcard™ + Plexstack™ = Supply, Labor and Space savings for your Laboratory

“The Multiplex solution for your lab is finally here...Versatile Multiplex platform + Highly-sensitive + High-throughput + Rapid detection time + Small fraction of Detection Reagent = Tremendous potential Supply, Labor and Space savings for your Laboratory” - Ben Liu, CSO

Plexigen is a privately held diagnostic company focusing on instrumentation and service for a wide array of clinical testing. The company has developed a highly-sensitive 3-D biological microarray, the Plexcard™, that overcomes the traditional 2-D array limitations of inflexibility and low throughput. This microarray is more powerful, accurate, quality assurable and more cost effective than presently available microarrays. The PlexStation 2080™ utilizes an elegant and patented design of stacking a 2-D Plexcard™ to form a customized 3-D Plexstack™. This enables the laboratorian to efficiently do large (and small) panels of biomarkers, antibodies, antigens, genes, and/or protein detection, on one instrument. The transformational methodology uses a very small fraction of the detection reagent compared with current platforms (e.g., ELISA and other immunoassays), potentially saving laboratories millions in annual expense.

The PlexStation 2080™ is available for select on-site, premarket valuation studies.

These statements have not been reviewed by the FDA.
This website is not meant as a substitute for professional medical advice.

Copyright © 2008, Plexigen, Inc. All rights reserved.